J Ga Public Health Assoc by Satsangi, Anamika & DeGroff, Amy
Planning a national-level data collection protocol to measure 
outcomes for the Colorectal Cancer Control Program
Anamika Satsangi, MPH and Amy DeGroff, PhD, MPH
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, 
GA
Abstract
Background—The Colorectal Cancer Control Program (CRCCP) of the Centers for Disease 
Control and Prevention (CDC) funded 30 grantees to partner with health systems with the goal of 
increasing screening for colorectal cancer (CRC).
Methods—Evaluators applied CDC’s Framework for Program Evaluation to design a national 
level outcome evaluation for measuring changes in CRC screening rates in partner health systems.
Results—The resulting evaluation design involves the collection and reporting of clinic-level 
CRC screening rates supplemented by various tools to support the reporting of high quality, 
reliable data.
Conclusions—The CRCCP evaluation represents a strong design to measure the primary 
outcome of interest, CRC screening rates, and public health practitioners can benefit from lessons 
learned about stakeholder involvement, data quality, and the role of evaluators in data 
dissemination.
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INTRODUCTION
Colorectal cancer (CRC) is a leading cause of cancer-related death in the U.S. (U.S. Cancer 
Statistics Working Group, 2016). Although screening reduces CRC incidence and mortality 
(Whitlock, Lin, Liles, Beil, & Fu, 2008), screening rates remain low (CDC, 2014). To 
increase screening rates, the Centers for Disease Control and Prevention (CDC) funded the 
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Colorectal Cancer Control Program (CRCCP) in 2015 for five years (CDC, 2016). Thirty 
grantees partnered with healthcare systems to implement evidence-based interventions 
(EBIs) such as provider and client reminders recommended in the Community Guide 
(Community Preventive Services Task Force, 2016) (Figure 1). This report describes an 
outcome evaluation designed to assess changes in screening rates in partner health systems.
METHODS
CDC evaluators applied the Framework for Program Evaluation to design a national-level 
CRCCP evaluation (Figure 1) (CDC, 1999). The framework includes (1) engaging 
stakeholders, (2) describing the program, (3) focusing the evaluation design, (4) gathering 
credible evidence, (5) justifying conclusions, and (6) ensuring use and sharing lessons 
learned.
Stakeholders, including CDC program consultants, leaders, CRCCP grantees, and healthcare 
experts, helped to define the purpose of the evaluation (i.e., program improvement, 
accountability) and provided guidance throughout the evaluation planning process. 
Evaluators created a program logic model (Appendix) describing CRCCP activities and 
outcomes that helped focus the design. Using the logic model, process and outcome 
evaluation questions were drafted and vetted with stakeholders. The primary outcome 
evaluation question was, “Do CRC screening rates increase in CRCCP partner health 
systems?” To examine this question, evaluators determined that screening rates would be 
assessed annually over the five-year program period. In consultation with stakeholders, 
evaluators learned that many grantees planned to work with subsets of primary care clinics 
within given health systems rather than all clinics in a given system. Therefore, clinic-level 
screening rate data (vs. health system-level) were needed.
Evaluators developed a data dictionary detailing the variables to be reported to CDC by 
grantees along with data collection tools and guidance documents. Variable selection was 
informed by the evaluation purpose and questions. With five grantees, materials were pilot-
tested to assess clarity, feasibility, and, for tools, functionality. Based on pilot testing, needed 
changes were incorporated. Evaluators also solicited advice from several national healthcare 
experts. Strategies to strengthen data quality were incorporated into the evaluation design. 
Finally, evaluators developed an analysis plan and selected dissemination strategies to ensure 
feedback of evaluation results.
RESULTS
Grantees reported baseline clinic-level data, including screening rates, for all clinics 
participating in the CRCCP. Given the longitudinal evaluation design, grantees also reported 
screening rates annually for each clinic through the end of the cooperative agreement. The 
data dictionary was comprised of 110 variables, including health system and clinic 
identification codes used to link records over time. Other variables captured descriptive data 
(e.g., health system name, clinic name, number of patients) and longitudinal data (e.g., 
screening rate, EBI implementation).
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Grantees calculated screening rates by medical chart review and/or electronic health record 
data. CDC evaluators developed a guidance document for grantees to support the consistent 
and accurate measurement of screening rates (CDC, 2016). For each clinic, grantees defined 
the 12-month measurement period (e.g., calendar year) and chose one of four screening rate 
measures recommended by CDC (e.g., National Committee for Quality Assurance, Health 
Resources and Services Administration). The guidance document also offered strategies to 
validate the screening rate.
Excel-based data collection forms were created, and grantees used them to gather baseline 
and annual data (Appendix 2). To improve data quality, these forms incorporated validation 
features (e.g., specified ranges, drop-down boxes). To report clinic data, grantees used a 
web-based data reporting system, Clinic Baseline and Annual Reporting System (CBARS), 
which incorporates similar data field edit checks to strengthen data quality. To support 
grantees in their data collection and reporting, evaluators conducted webinars, provided 
individual technical assistance, and maintained a document of frequently asked questions.
Baseline data for clinics recruited in program year 1 were analyzed by CDC, and reports 
were developed for stakeholders. Future dissemination efforts will use data visualization 
software that allows grantees to examine their own data.
DISCUSSION/CONCLUSIONS
Representing the integration of public health and primary care, the CRCCP offers an 
opportunity to increase CRC screening. Using CDC’s Framework for Evaluation, a strong 
evaluation has been designed to assess the CRCCP’s primary outcome of interest, CRC 
screening rates, using medical record data.
Several lessons can be derived from this experience. First, conducting high quality, 
systematic outcome evaluations of Federal programs such as the CRCCP is difficult when 
many grantees and potentially hundreds of implementation sites are involved. Such scenarios 
inherently involve data access and quality challenges (DeGroff, Schooley, Chapel, & Poister, 
2010). However, broad stakeholder involvement ensured that CDC crafted a meaningful 
outcome evaluation question, identified a feasible data collection strategy that was not overly 
burdensome, and selected data variables accessible to all participating health system clinics. 
Second, CDC evaluators integrated various strategies to ensure data quality and strengthen 
reliability, including developing a data dictionary with standardized variable definitions, 
developing guidance on how to measure screening rates, providing data collection forms and 
a web-based reporting system with built-in validation features, and delivering various types 
of technical support. Finally, evaluators have a critical role to play in data use such as 
facilitating interpretation. For the CRCCP, data feedback mechanisms are in place, with 
more sophisticated dissemination efforts being planned using data visualization software. 
Timely dissemination of data to grantees in a digestible fashion enables meaningful data 
feedback and use, and reinforces the importance of grantees reporting high-quality data.
Evaluation of public health programs is essential to ensure accountability to stakeholders, 
including funders, and to improve programs. Good evaluation planning is foundational to 
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realizing these aims. Public health practitioners and evaluators can apply CDC’s Framework 
for Program Evaluation and the lessons identified here to support their own evaluation 
planning.
Acknowledgments
The authors thank the entire CRCCP evaluation team for their contributions in designing CDC’s CRCCP 
evaluation.
References
CDC. Framework for program evaluation in public health. 1999. Retrieved September 20, 2016 from 
http://www.cdc.gov/eval/framework/index.htm
CDC. Behavioral Risk Factor Surveillance System Survey Data. 2014. 
CDC. Colorectal Cancer Control Program. 2016. Retrieved September 22, 2016 from http://
www.cdc.gov/cancer/crccp/about.htm
CDC. Guidance for Measuring Colorectal Cancer (CRC) Screening Rates in Health System Clinics. 
2016. Retrived November 15, 2016 from http://www.cdc.gov/cancer/crccp/
guidance_measuring_crc_screening_rates.htm
Community Preventive Services Task Force. The Community Guide. 2016. Retrieved September 22, 
2016 from https://www.thecommunityguide.org/topic/cancer
DeGroff A, Schooley M, Chapel T, Poister TH. Challenges and strategies in applying performance 
measurement to federal public health programs. Eval Program Plann. 2010; 33(4):365–372. DOI: 
10.1016/j.evalprogplan.2010.02.003 [PubMed: 20303176] 
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2013 Incidence and 
Mortality Web-based Report. 2016. Retrieved September 25, 2016 from https://nccd.cdc.gov/uscs/
Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated 
systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 149(9):638–
658. [PubMed: 18838718] 
Appendix 1 CRCCP Logic Model
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Appendix 2 Screening Rate and Monitoring and Quality Improvement 
Sections of CRCCP Annual Clinic Data Collection Form
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Map of CRCCP grantees
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CDC Framework for Program Evaluation
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